Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open-angle glaucoma

Cornea

Volumn 31, Issue 8, 2012, Pages 883-886

  Shazly, Tarek A ^a,b   Latina, Mark A ^c   Dagianis, John J ^d   Chitturi, Satyakant ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ASSIUT UNIVERSITY   (Egypt)

^c Reading Health Center   (United States)

^d Nashua Eye Associates   (United States)

^e ANDHRA MEDICAL COLLEGE   (India)

Author keywords

central corneal thickness; intraocular pressure; ocular hypertension; primary open angle glaucoma; selective laser trabeculoplasty

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CORNEA THICKNESS; FEMALE; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER SURGERY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELECTIVE LASER TRABECULOPLASTY; SURGICAL TECHNIQUE; TRABECULOPLASTY; TREATMENT OUTCOME;

AGED; CORNEA; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; MALE; OCULAR HYPERTENSION; ORGAN SIZE; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 84863778637     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318243f684     Document Type: Article

References (21)

1. Latina MA, Tumbocon JA. Selective laser trabeculoplasty: A new treatment option for open angle glaucoma. Curr Opin Ophthalmol. 2002;13: 94-96.
2. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology. 1998;105:2082-2090.
3. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clin Ophthalmol. 2010;5:5-10.
4. Mao AJ, Pan XJ, McIlraith I, et al. Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Glaucoma. 2008;17:449-454.
5. Hodge WG, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: Results from a randomized clinical trial. Br J Ophthalmol. 2005;89:1157-1160.
6. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty v argon laser trabeculoplasty: A prospective randomised clinical trial. Br J Ophthalmol. 1999;83:718-722.
7. Shazly TA, Latina MA. Is the success of selective laser trabeculoplasty in one eye predictive of success in the fellow eye of patients with ocular hypertension and primary open-angle glaucoma? Invest Ophthalmol Vis Sci. 2009;50:Abstract 156.
8. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: A prospective, nonrandomized pilot study. Arch Ophthalmol. 2003;121: 957-960.
9. Kano K, Kuwayama Y, Mizoue S, et al. Clinical results of selective laser trabeculoplasty [in Japanese]. Nihon Ganka Gakkai Zasshi. 1999;103: 612-616.
10. Gracner T. Intraocular pressure response to selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Ophthalmologica. 2001;215:267-270.
11. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol. 2006;41:449-456.
12. Johnson PB, Katz LJ, Rhee DJ. Selective laser trabeculoplasty: Predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol. 2006;90:741-743.
13. Shazly TA, Latina MA, Dagianis JJ, et al. Effect of prior cataract surgery on the long-term outcome of selective laser trabeculoplasty. Clin Ophthalmol. 2011;5:377-380.
14. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720.
15. European Glaucoma Prevention (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114:3-9.
16. Leske MC, Wu SY, Hennis A. Risk factors for incident open-angle glaucoma: The Barbados Eye Studies. Ophthalmology. 2008;115:85-93.
17. The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients. Ophthalmology. 1998;105: 1137-1145.
18. Kooner KS, Tokunaga J. Central Corneal Thickness and Argon Laser Trabeculoplasty Outcomes in African Americans with Primary Open Angle Glaucoma. Invest Ophthalmol Vis Sci. 2006;47:Abstract 4430.
19. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh). 1975;53:34-43.
20. Wolfs RC, Klaver CC, Vingerling JR, et al. Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol. 1997;123:767-772.
21. Harasymowycz PJ, Papamatheakis DG, Ennis M, et al. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea. 2007;26:34-41.